LONDON (AP) — Drugmaker Pfizer Inc. has signed a deal with a U.N.-backed group to allow other manufacturers to make its experimental COVID-19 pill, a move that could make the treatment available to more than half of the world’s population.
News in :90 – Oct. 1, 2021
Drugmaker Merck will soon ask health officials to authorize its experimental COVID-19 pill and the St. Thomas Office for Diversity, Equity and Inclusion addressed a visit from a TikTok personality. Reporter Luana Karl has today’s News in :90.